New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
Human Respiratory Syncytial Virus (hRSV) is one of the major causes of acute lower respiratory tract infections (ALRTI) worldwide, leading to significant levels of immunocompromisation as well as morbidity and mortality in infants. Its main target of infection is the ciliated epithelium of the lungs...
Main Authors: | Nicolás M. S. Gálvez, Jorge A. Soto, Alexis M. Kalergis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/8/1753 |
Similar Items
-
Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
by: Catalina A. Andrade, et al.
Published: (2020-06-01) -
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
by: Emma Rey-Jurado, et al.
Published: (2017-09-01) -
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
by: Gaspar A. Pacheco, et al.
Published: (2023-07-01) -
M2-2 gene as a new alternative molecular marker for phylogenetic, phylodynamic, and evolutionary studies of hRSV
by: Denis Bruno S.M. Nunes, et al.
Published: (2022-09-01) -
Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
by: Sara Boccalini, et al.
Published: (2023-09-01)